Abstract
AB062. LAG3 gene as a potential prognostic factor and tumor microenvironment remodeling indicator in thymic epithelial tumors: a TCGA data-based study
Mediastinum
2024;
8:
AB062
.
(30 December 2024)
Abstract
AB061. Long-term outcomes and characteristics of unresectable or inoperable thymic malignancies
Mediastinum
2024;
8:
AB061
.
(30 December 2024)
Abstract
AB060. Multiplex immunofluorescence analysis of potential targets in thymic epithelial tumors
Mediastinum
2024;
8:
AB060
.
(30 December 2024)
Abstract
AB059. The antero-superior mediastinum as unique metastatic site of primary unknown desmoplastic melanoma: a case report
Mediastinum
2024;
8:
AB059
.
(30 December 2024)
Abstract
AB058. Rebound thymic hyperplasia and immune related adverse events: reality or fantasy—a case report
Mediastinum
2024;
8:
AB058
.
(30 December 2024)
Abstract
AB057. The practice, intent, and outcome of radiotherapy in thymic epithelial tumors—results from a national cohort
Mediastinum
2024;
8:
AB057
.
(30 December 2024)
Abstract
AB056. Spatial analysis of T-cell development in type B2 thymoma tumour microenvironment at single-cell resolution
Mediastinum
2024;
8:
AB056
.
(30 December 2024)
Abstract
AB055. Tumor-T cell interactions in thymic epithelial tumors
Mediastinum
2024;
8:
AB055
.
(30 December 2024)
Abstract
AB054. A case report of thymoma resection with invasion into the superior vena cava
Mediastinum
2024;
8:
AB054
.
(30 December 2024)
Abstract
AB053. Assessing the predictive significance of tumor size in thymoma and thymic carcinoma: an analysis utilizing SEER database with propensity matching
Mediastinum
2024;
8:
AB053
.
(30 December 2024)
Abstract
AB052. Rare tumors biobanking and artificial intelligence (AI): complexity and synergism
Mediastinum
2024;
8:
AB052
.
(30 December 2024)
Abstract
AB051. Phase II, neo-adjuvant pembrolizumab, paclitaxel, carboplatin therapy followed by post operational pembrolizumab consolidation in locally advanced thymic epithelial tumor
Mediastinum
2024;
8:
AB051
.
(30 December 2024)
Abstract
AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma
Mediastinum
2024;
8:
AB050
.
(30 December 2024)
Abstract
AB049. Sequential induction chemoradiotherapy for locally advanced thymic tumors: a phase II clinical trial
Mediastinum
2024;
8:
AB049
.
(30 December 2024)
Abstract
AB048. The feasibility and efficacy of induction therapy followed by surgery for advanced thymic carcinoma
Mediastinum
2024;
8:
AB048
.
(30 December 2024)
Abstract
AB047. Comparison of outcomes of minimally invasive surgery versus sternotomy for early-stage thymic epithelial tumors: a single-center retrospective analysis
Mediastinum
2024;
8:
AB047
.
(30 December 2024)
Abstract
AB046. Clinical landscape and immunological features of patients with thymic carcinoma
Mediastinum
2024;
8:
AB046
.
(30 December 2024)
Abstract
AB045. Impact of relative dose intensity of platinum-base chemotherapy as first-line treatment in patients with thymic epithelial tumors
Mediastinum
2024;
8:
AB045
.
(30 December 2024)
Abstract
AB044. Surveillance trends after resection for thymic malignancy
Mediastinum
2024;
8:
AB044
.
(30 December 2024)
Abstract
AB043. One case report of recurrence of atypical A thymoma subsequent to undergoing surgery for type AB thymoma
Mediastinum
2024;
8:
AB043
.
(30 December 2024)
Abstract
AB042. Deep dive into the NEJM study suggesting health consequences after thymectomy
Mediastinum
2024;
8:
AB042
.
(30 December 2024)
Abstract
AB041. Deep learning discriminates thymic epithelial tumors histological subtypes using digital pathology
Mediastinum
2024;
8:
AB041
.
(30 December 2024)
Abstract
AB040. Thymic epithelial tumors and haematological malignancies: a monocentric experience
Mediastinum
2024;
8:
AB040
.
(30 December 2024)
Abstract
AB039. Complex management of thymic epithelial tumors associated with immuno- haematological disorders at the diagnosis: case reports of our experience
Mediastinum
2024;
8:
AB039
.
(30 December 2024)
Abstract
AB038. Thymomatous myasthenia gravis is associated with fluctuations in CD4-positive T-cell subsets through the activity of the PI3K-Akt-mTOR pathway
Mediastinum
2024;
8:
AB038
.
(30 December 2024)
Abstract
AB037. AI-powered differentiation of thymomas (A and B3) and thymic carcinoma using histopathological analysis of H&E whole slide images
Mediastinum
2024;
8:
AB037
.
(30 December 2024)
Abstract
AB036. The contribution of H.K. Müller-Hermelink to the understanding of human thymic pathology
Mediastinum
2024;
8:
AB036
.
(30 December 2024)
Abstract
AB035. Mediastinal lesion characterization and prognostication using diffusion MRI: from whole lesion to target zone with dynamic approach
Mediastinum
2024;
8:
AB035
.
(30 December 2024)
Abstract
AB034. Single-cell RNA-seq reveals altered gene expression and cellular composition in thymic epithelial cells of type B thymoma
Mediastinum
2024;
8:
AB034
.
(30 December 2024)
Abstract
AB033. Impact of tumor-infiltrating lymphocytes, tertiary lymphoid structures, and blood inflammatory markers in thymic cancer patients undergoing surgery
Mediastinum
2024;
8:
AB033
.
(30 December 2024)
Abstract
AB032. Clinical outcome and immunophenotype in patients with thymic epithelial tumors
Mediastinum
2024;
8:
AB032
.
(30 December 2024)
Abstract
AB031. Clinical outcome and serum cytokinome profile in patients with thymic epithelial tumors
Mediastinum
2024;
8:
AB031
.
(30 December 2024)
Abstract
AB030. Metabolic profiles and clinical outcome in patients with thymic epithelial tumors
Mediastinum
2024;
8:
AB030
.
(30 December 2024)
Abstract
AB029. Short-term outcomes of uniportal subxiphoid thoracoscopic thymectomy for anterior mediastinal tumors
Mediastinum
2024;
8:
AB029
.
(30 December 2024)
Abstract
AB028. Spatial transcriptomics to dissect the cellular heterogeneity in thymic carcinoma
Mediastinum
2024;
8:
AB028
.
(30 December 2024)
Abstract
AB027. Insights into hemi-clamshell incision for mediastinal tumor resection
Mediastinum
2024;
8:
AB027
.
(30 December 2024)
Abstract
AB026. Paraplegia as a first clinical presentation of giant cell tumor of the thoracic spine presenting as a posterior mediastinal tumor with cutaneous tuberculosis: a case report
Mediastinum
2024;
8:
AB026
.
(30 December 2024)
Abstract
AB025. Primary posterior mediastinal benign leiomyoma arising from accessory hemiazygos vein: a case report
Mediastinum
2024;
8:
AB025
.
(30 December 2024)
Abstract
AB024. Evaluation of surgical treatment of myasthenia gravis complicated thymoma
Mediastinum
2024;
8:
AB024
.
(30 December 2024)
Abstract
AB023. The new TNM classification and Masaoka staging system prognosis of thymoma: a retrospective single-center study
Mediastinum
2024;
8:
AB023
.
(30 December 2024)
Abstract
AB022. Tumor size as an independent prognosticator in advanced thymic epithelial tumors requiring a combined resection of adjacent organs and dissemination
Mediastinum
2024;
8:
AB022
.
(30 December 2024)
Abstract
AB021. Remission of recurrent pleural thymoma achieved with lenvatinib as a single agent: a case report
Mediastinum
2024;
8:
AB021
.
(30 December 2024)
Abstract
AB020. Transforming growth factor-beta 1 as an active biomarker along with programmed cell death ligand-1 expression for the malignant potential in thymic epithelial tumors
Mediastinum
2024;
8:
AB020
.
(30 December 2024)
Abstract
AB019. Prognostic impact of serum CYFRA 21-1 levels on postoperative outcomes of thymic epithelial tumors
Mediastinum
2024;
8:
AB019
.
(30 December 2024)
Abstract
AB018. Superior mediastinal tumor, distribution of the diseases, and its clinical course
Mediastinum
2024;
8:
AB018
.
(30 December 2024)
Abstract
AB017. Robotic thymectomy for Morvan’s syndrome associated with thymoma: a case report
Mediastinum
2024;
8:
AB017
.
(30 December 2024)
Abstract
AB016. A case of invasive thymoma with rapid response to PAC therapy, after an early postoperative recurrence
Mediastinum
2024;
8:
AB016
.
(30 December 2024)
Abstract
AB015. Remarkable long-term survival following surgical resection and chemotherapy in type A thymoma with bilateral pulmonary metastasis: a rare case report
Mediastinum
2024;
8:
AB015
.
(30 December 2024)
Abstract
AB014. Impact of size of primary tumor on survival in thymic epithelial tumor
Mediastinum
2024;
8:
AB014
.
(30 December 2024)
Abstract
AB013. Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma
Mediastinum
2024;
8:
AB013
.
(30 December 2024)
Abstract
AB012. Extent of thymectomy in anti-acetylcholine receptor antibody-positive thymoma
Mediastinum
2024;
8:
AB012
.
(30 December 2024)
Abstract
AB011. Robotic thymectomy is an ideal surgical treatment for Good’s syndrome: a case series
Mediastinum
2024;
8:
AB011
.
(30 December 2024)
Abstract
AB010. Surgical treatment strategy for thymic cancer invading the aorta: a case report
Mediastinum
2024;
8:
AB010
.
(30 December 2024)
Abstract
AB009. Impact of neoadjuvant therapy followed by surgical intervention for thymic carcinoma patients
Mediastinum
2024;
8:
AB009
.
(30 December 2024)
Abstract
AB008. A case of thymic typical carcinoid successfully resected by robot-assisted thoracoscopic surgery
Mediastinum
2024;
8:
AB008
.
(30 December 2024)
Abstract
AB007. A resected case of mediastinal myxoid liposarcoma: a case report
Mediastinum
2024;
8:
AB007
.
(30 December 2024)
Abstract
AB006. Two cases of mediastinal germ cell tumor with somatic-type malignancy with neuroendocrine tumor
Mediastinum
2024;
8:
AB006
.
(30 December 2024)
Abstract
AB005. Resection of an epithelioid hemangioendothelioma arising from the superior vena cava: a case report
Mediastinum
2024;
8:
AB005
.
(30 December 2024)
Abstract
AB004. A case report of mediastinal germ cell tumor with vasculogenic mesenchymal tumor components sharing a PTEN mutation with acute megakaryoblastic leukemia
Mediastinum
2024;
8:
AB004
.
(30 December 2024)
Abstract
AB003. Cytoreductive surgery with radical pleurectomy/ decortication and intraoperative photodynamic therapy as a treatment for stage IVa and pleural recurrence thymic tumors
Mediastinum
2024;
8:
AB003
.
(30 December 2024)
Abstract
AB002. Patterns of lymph node metastasis in patients with neuroendocrine thymic tumors: a retrospective study of 72 cases
Mediastinum
2024;
8:
AB002
.
(30 December 2024)
Abstract
AB001. Late multiple extra-thoracic metastasis from thymoma biopsy seeding: a case report
Mediastinum
2024;
8:
AB001
.
(30 December 2024)
Download the Full Issue PDF(679KB)
Disclosure:
The “Abstract Book for the 14th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2024)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding.
